183 related articles for article (PubMed ID: 11197050)
1. Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease.
Oshitani N; Hato F; Matsumoto T; Jinno Y; Sawa Y; Hara J; Nakamura S; Seki S; Arakawa T; Kitano A; Kitagawa S; Kuroki T
J Gastroenterol Hepatol; 2000 Dec; 15(12):1400-3. PubMed ID: 11197050
[TBL] [Abstract][Full Text] [Related]
2. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
[TBL] [Abstract][Full Text] [Related]
3. IgG subclasses of anti Saccharomyces cerevisiae antibody in inflammatory bowel disease.
Oshitani N; Hato F; Jinno Y; Sawa Y; Nakamura S; Matsumoto T; Seki S; Kitagawa S; Arakawa T
Eur J Clin Invest; 2001 Mar; 31(3):221-5. PubMed ID: 11264649
[TBL] [Abstract][Full Text] [Related]
4. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
[TBL] [Abstract][Full Text] [Related]
5. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.
Giaffer MH; Clark A; Holdsworth CD
Gut; 1992 Aug; 33(8):1071-5. PubMed ID: 1398231
[TBL] [Abstract][Full Text] [Related]
7. Anti-Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease.
El-Matary W; Dupuis K; Sokoro A
Acta Paediatr; 2015 Aug; 104(8):827-30. PubMed ID: 25877674
[TBL] [Abstract][Full Text] [Related]
8. Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease.
Bernstein CN; Orr K; Blanchard JF; Sargent M; Workman D
Can J Gastroenterol; 2001 Aug; 15(8):499-504. PubMed ID: 11544532
[TBL] [Abstract][Full Text] [Related]
9. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.
Forcione DG; Rosen MJ; Kisiel JB; Sands BE
Gut; 2004 Aug; 53(8):1117-22. PubMed ID: 15247177
[TBL] [Abstract][Full Text] [Related]
10. Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease.
Kotze LM; Nisihara RM; Utiyama SR; Kotze PG; Theiss PM; Olandoski M
Arq Gastroenterol; 2010; 47(3):242-5. PubMed ID: 21140083
[TBL] [Abstract][Full Text] [Related]
11. Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis.
Müller S; Styner M; Seibold-Schmid B; Flogerzi B; Mähler M; Konrad A; Seibold F
World J Gastroenterol; 2005 Nov; 11(44):6988-94. PubMed ID: 16437604
[TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
13. Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.
Hoffman IE; Demetter P; Peeters M; De Vos M; Mielants H; Veys EM; De Keyser F
Ann Rheum Dis; 2003 May; 62(5):455-9. PubMed ID: 12695160
[TBL] [Abstract][Full Text] [Related]
14. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease.
Barta Z; Csípõ I; Szabó GG; Szegedi G
World J Gastroenterol; 2003 Oct; 9(10):2308-12. PubMed ID: 14562398
[TBL] [Abstract][Full Text] [Related]
15. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
Preda CM; Diculescu M; Mirea V; Marica C; Vermeire S; Rutgeerts P; Oproiu A
Rom J Gastroenterol; 2005 Mar; 14(1):23-6. PubMed ID: 15800689
[TBL] [Abstract][Full Text] [Related]
16. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
[TBL] [Abstract][Full Text] [Related]
18. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
Sandborn WJ; Loftus EV; Colombel JF; Fleming KA; Seibold F; Homburger HA; Sendid B; Chapman RW; Tremaine WJ; Kaul DK; Wallace J; Harmsen WS; Zinsmeister AR; Targan SR
Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844
[TBL] [Abstract][Full Text] [Related]
20. The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn's disease and predicting inflammatory disease.
Kaila B; Orr K; Bernstein CN
Can J Gastroenterol; 2005 Dec; 19(12):717-21. PubMed ID: 16341311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
